Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omic is a precision health and biotechnology company that leverages multi-omics and artificial intelligence to transform preventative medicine and drug discovery. The company's platform analyzes thousands of proteins and metabolites from a single blood sample to provide a comprehensive map of an individual's health and biological age. By identifying early biomarkers of chronic diseases, Omic enables personalized interventions and supports the development of targeted therapies. The company aims to shift healthcare from a reactive model to a proactive, data-driven approach to longevity and wellness. The platform integrates high-throughput molecular data with machine learning to deliver actionable health intelligence directly to consumers and clinical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omic.